SCHEMBL18569737

SCHEMBL18569737

C[C@@H]1CO[C@@](C)(CCO)C(=O)N1Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.41
ELANE P08246 2/20 0.39
HSD11B1 P28845 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CTSG P08311 1/20 0.38
PRTN3 P24158 1/20 0.38
CACNA1G O43497 2/20 0.38
CACNA1H O95180 2/20 0.38
CACNA1I Q9P0X4 2/20 0.38
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
GAA P10253 1/20 0.37
EHMT2 Q96KQ7 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
LMNA P02545 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16399764 1.00 BRD4 (0.41) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16400195 0.85 ELANE (0.40) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16399520 0.84 ELANE (0.37) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16399773 0.83 BRD4 (0.40) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16400119 0.82 ELANE (0.39) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16399366 0.82 HSD11B1 (0.40) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16399349 0.81 ELANE (0.38) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL16400657 0.79 HSD11B1 (0.35) BRD4ELANEHSD11B1ALDH1A1MAPT
SCHEMBL17685931 0.78 SMYD2 (0.36) ELANEHSD11B1ALDH1A1MAPTHSD17B10
SCHEMBL16399447 0.74 AMPD2 (0.44) ELANEALDH1A1MAPTHSD17B10CTSG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004084-B1 SUBSTITUTED BENZOXAZOLES Bayer Pharma AG (DE) 2017-03-01 EP disclosed